Kirsten Kester is Obsidian’s Senior Vice President of Business Development, a role in which she defines and executes the company’s corporate and business development strategy. Previously, she was Senior Director at Huron Consulting (formerly Frankel Group), where she served on the leadership team for the life sciences practice. At Huron, Ms. Kester advised a diverse set of biopharma companies and their investors on corporate strategy, commercial strategy, pipeline and portfolio planning, and clinical development strategy. She also advised clients on business development transactions and led due diligence in support of investment decisions. Prior to joining Huron, Ms. Kester held roles in the Healthcare Investment Banking Group at Goldman Sachs and at Generation Health, a start-up pharmacogenomic testing company that was acquired by CVS Caremark. She holds a B.A. in biology from Harvard College and an MBA from Harvard Business School.